UPLC and MS systems purchased by the National Cancer Institute
Waters has announced that the National Cancer Institute's Centre for Cancer Research in Bethesda, Maryland, USA, has purchased one of the company's ACQUITY UPLC/Synapt High Definition Mass Spectrometers (HDMS) and an ACQUITY UPLC/Xevo TQ MS system for the centre's metabolomics research programs.
Waters has announced that the National Cancer Institute's Centre for Cancer Research in Bethesda, Maryland, USA, has purchased one of the company's ACQUITY UPLC/Synapt High Definition Mass Spectrometers (HDMS) and an ACQUITY UPLC/Xevo TQ MS system for the centre's metabolomics research programmes.
The research is aimed at discovering small molecule metabolites, or biomarkers, associated with cancer susceptibility and diagnosis, treatment efficacy and the adverse effects of medicines and other chemicals. Identifying and quantifying the thousands of metabolic biomarkers present in a complex sample such as urine requires sensitive instruments and powerful software. Researchers are confident that these tools will lead to a better understanding of the mechanisms of the disease and its diagnosis, treatment and prevention.
The UPLC system employs 1.7 micron particles in analytical columns that the company claims permit higher chromatographic resolution, shorter analysis times and the use of less solvent per sample. Paired with tandem quadrupole and quadrupole time-of-flight/ion mobility mass spectrometry, the reported sharper chromatographic peaks, increased peak heights and better signal-to-noise performance of UPLC technology improves the mass spectrometer's ability to ionize molecules. The MS system is an advanced tandem quadrupole mass spectrometer that tackles the most demanding quantification applications for target compounds at low concentrations in highly complex and diverse samples.
For more information on the National Cancer Institute visit www.cancer.gov
More information about Waters and its products are available at www.waters.com
Best of the Week: Food Analysis, Chemical Migration in Plastic Bottles, STEM Researcher of the Year
December 20th 2024Top articles published this week include the launch of our “From Lab to Table” content series, a Q&A interview about using liquid chromatography–high-resolution mass spectrometry (LC–HRMS) to assess chemical hazards in plastic bottles, and a piece recognizing Brett Paull for being named Tasmanian STEM Researcher of the Year.
Using LC-MS/MS to Measure Testosterone in Dried Blood Spots
December 19th 2024Testosterone measurements are typically performed using serum or plasma, but this presents several logistical challenges, especially for sample collection, storage, and transport. In a recently published article, Yehudah Gruenstein of the University of Miami explored key insights gained from dried blood spot assay validation for testosterone measurement.
Determination of Pharmaceuticals by Capillary HPLC-MS/MS (Dec 2024)
December 19th 2024This application note demonstrates the use of a compact portable capillary liquid chromatograph, the Axcend Focus LC, coupled to an Agilent Ultivo triple quadrupole mass spectrometer for quantitative analysis of pharmaceutical drugs in model aqueous samples.
